CTTACC

The CTTACC event, presented by the UCSF Department of Laboratory Medicine and the UCSF Center for Research in Transfusion Medicine and Cellular Therapies, is hosted at the Omni Scottsdale Resort & Spa at Montelucia in Scottsdale, United States. This conference is the seventh in a series focused on 'Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine'. Aimed at improving outcomes for trauma patients, the conference emphasizes the critical potential of cellular therapies and novel blood products in resuscitation and transfusion medicine. Previous conferences have fostered cross-disciplinary collaborations leading to grants for pre-clinical studies and clinical trials, underscoring the mission to support the translation of novel therapies in this vital field.The gathering aims to unite experts from various sectors including blood bankers, cell therapy producers, clinicians, basic scientists, and representatives from organizations such as the FDA, AFIRM, MTEC, NIH, AABB, DARPA, BARDA, and the Department of Defense. Key topics for discussion encompass military health sessions focusing on battlefield medicine, including prolonged casualty care and innovative blood products. Additionally, the conference will explore the integration of technology in gene editing and therapy, as well as cellular therapies in chronic and acute critical illnesses. Notable areas of focus include regenerative approaches to treating burns, traumatic brain injuries (TBI), and sepsis. The event will also feature an FDA regulatory panel addressing the ethical and legal challenges surrounding novel products and technologies. Focus groups will tackle next-generation solutions for wound healing and the challenges of developing a dried plasma product for both military and civilian use.The conference will include presentations from distinguished speakers such as Zaid Fadul, Vincent Ho, Travis Polk, Toby Silverman, and Timothy Billiar. With a target audience reach across the USA, this gathering is poised to advance the conversation and development of innovative therapies in trauma and critical care medicine, marking a significant step towards overcoming existing barriers and enhancing therapeutic options in this essential healthcare field.